Sectoral Asset Management Inc Aligos Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.08 - $12.2 $35,168 - $206,277	-16,908 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$20.3 - $33.6 $36,540 - $60,480	-1,800 Reduced 9.62%	16,908 $345,000
Q4 2020 Feb 12, 2021	BUY	$13.2 - $32.74 $246,945 - $612,499	18,708 New	18,708 $517,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.